Data of Nakshatri and colleagues indicated that NF-κB is constitutively activated in MDA-MB-435 breast cancer cells due to low expression levels of the inhibitory proteins IκB-α, IκB-β and IκB-γ [51]. The gene discussed is NFKB1; the disease is breast carcinoma.